-
1Academic Journal
المؤلفون: E. A. Tarabrin, M. Sh. Khubutiya, A. S. Guseva, E. A. Ermakova, E. I. Pervakova, S. V. Zhuravel, A. M. Gasanov, V. G. Kotandzhyan, N. A. Karchevskaya, T. E. Kallagov, I. U. Ibavov, M. S. Kevorkova, Z. G. Berikkhanov, M. Yu. Ivanova, Е. А. Тарабрин, М. Ш. Хубутия, А. С. Гусева, Е. А. Ермакова, Э. И. Первакова, С. В. Журавель, А. М. Гасанов, В. Г. Котанджян, Н. А. Карчевская, Т. Э. Каллагов, И. У. Ибавов, М. С. Кеворкова, З. Г. Берикханов, М. Ю. Иванова
المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 16, № 4 (2024); 491-499 ; Трансплантология; Том 16, № 4 (2024); 491-499 ; 2542-0909 ; 2074-0506
مصطلحات موضوعية: экстракорпоральная мембранная оксигенация, non-langerhans cell histiocytosis, rejection, bronchial stenosis, extracorporeal membrane oxygenation, нелангергансоклеточный гистиоцитоз, отторжение, стеноз бронха
وصف الملف: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/942/909; Хубутия М.Ш., Чучалин А.Г., Абакумов М.М., Авдеев С.Н., Тимербаев В.Х., Поплавский И.В., и др. Первая трансплантация легких в НИИ скорой помощи им. Н.В. Склифосовского. Трансплантология. 2011;(2–3):5–9. https://doi.org/10.23873/2074-0506-2011-0-2-3-5-9; Chambers DC, Perch M, Zucker mann A, Cherikh WS, Harhay MO, Hayes D Jr, et al. International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report – 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40(10):1060–1072. PMID: 34446355 https://doi.org/10.1016/j.healun.2021.07.021; Biswas Roy S, Panchanathan R, Walia R, Varsch KE, Kang P, Huang J, et al. Lung retransplantation for chronic rejection: a single-center experience. Ann Thorac Surg. 2018;105(1):221–227. PMID: 29100649 https://doi.org/10.1016/j.athoracsur.2017.07.025; Kawut SM. Lung retransplanta tion. Clin Chest Med. 2011;32(2):367– 377. PMID: 21511096 https://doi.org/10.1016/j.ccm.2011.02.013; Crotti S, Iotti GA, Lissoni A, Belliato M, Zanierato M, Chierichetti M, et al. Organ allocation waiting time during extracorporeal bridge to lung transplant affects outcomes. Chest. 2013;144(3):1018–1025. PMID: 23599162 https://doi.org/10.1378/chest.12-1141; Inci I, Ehrsam JP, Van Raemdonck D, Ceulemans LJ, Krüger T, Koutsokera A, et al. Extracorporeal life support as a bridge to pulmonary retransplantation: prognostic factors for survival in a multicentre cohort analysis. Eur J Cardiothorac Surg. 2022;61(2):405–412. PMID: 34935039 https://doi.org/10.1093/ejcts/ezab514; Collaud S, Benden C, Ganter C, Hillin ger S, Opitz I, Schneiter D, et al. Extracorporeal life support as bridge to lung retransplantation: a multicenter pooled data analysis. Ann Thorac Surg. 2016;102(5):1680–1686. PMID: 27424471 https://doi.org/10.1016/j.athoracsur.2016.05.014; Grimm JC, Valero V 3rd, Kilic A, Magruder JT, Merlo CA, Shah PD, et al. Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation. JAMA Surg. 2015;150(6):547–553. PMID: 25874575 https://doi.org/10.1001/jamasurg.2015.12; https://www.jtransplantologiya.ru/jour/article/view/942
-
2Academic Journal
المؤلفون: N. A. Karchevskaya, M. S. Kevorkova, E. А. Tarabrin, T. Е. Kallagov, I. U. Ibavov, E. I. Pervakova, A. L. Cherniaev, M. V. Samsonova, M. Sh. Khubutiya, A. G. Chuchalin, Н. А. Карчевская, М. С. Кеворкова, Е. А. Тарабрин, Т. Э. Каллагов, И. У. Ибавов, Э. И. Первакова, А. Л. Черняев, М. В. Самсонова, М. Ш. Хубутия, А. Г. Чучалин
المصدر: PULMONOLOGIYA; Том 32, № 6 (2022); 899-905 ; Пульмонология; Том 32, № 6 (2022); 899-905 ; 2541-9617 ; 0869-0189
مصطلحات موضوعية: ингибитор α 1 -протеиназы, lung transplantation, pulmonary emphysema, augmentation therapy, α 1 -proteinase inhibitor, трансплантация легких, эмфизема легких, заместительная терапия
وصف الملف: application/pdf
Relation: https://journal.pulmonology.ru/pulm/article/view/4090/3474; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4090/1422; Sandhaus R.A., Turino G., Brantly M.L. et al. The diagnosis and management of alpha-1 antitrypsin deficiency in the adult. Chronic Obstr. Pulm. Dis. 2016; 3 (3): 668-682. DOI:10.15326/jcopdf.3.3.2015.0182.; Weill D., Benden C., Corris P.A. et al. A consensus document for the selection of lung transplant candidates: 2014 - an update from the pulmonary transplantation council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 2015; 34 (1): 1-15. DOI:10.1016/j.healun.2014.06.014.; Stoller J.K., Aboussouan L.S. Alpha1-antitrypsin deficiency. 5: intravenous augmentation therapy: current understanding. Thorax. 2004; 59 (8): 708-712. DOI:10.1136/thx.2003.006544.; Sandhaus R.A. Alpha1-antitrypsin deficiency. 6: new and emerging treatments for alpha1-antitrypsin deficiency. Thorax. 2004; 59 (10): 904-909. DOI:10.1136/thx.2003.006551.; Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2021 Report. Available at: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf [Accessed: October 09, 2021].; Anglès R., Tenorio L., Roman A. et al. Lung transplantation for emphysema. Lung hyperinflation: incidence and outcome. Transpl. Int. 2005; 17 (12): 810-814. DOI:10.1007/s00147-004-0714-7.; Faccioli E., Terzi S., Pangoni A. et al. Extracorporeal membrane oxygenation in lung transplantation: Indications, techniques and results. World J. Transplant. 2021; 11 (7): 290-302. DOI:10.5500/wjt.v11.i7.290.; Yusen R.D., Edwards L.B., Dipchand A.I. et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third adult lung and heart-lung transplant report-2016; Focus theme: Primary diagnostic indications for transplant. J. Heart Lung Transplant. 2016; 35 (10): 1170-1184. DOI:10.1016/j.healun.2016.09.001.; Tanash H.A., Riise G.C., Ekström M.P. et al. Survival benefit of lung transplantation for chronic obstructive pulmonary disease in Sweden. Ann. Thorac. Surg. 2014; 98 (6): 1930-1935. DOI:10.1016/j.athoracsur.2014.07.030.; Chapman K.R., Stockley R.A., Dawkins C. et al. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD. 2009; 6 (3): 177-184. DOI:10.1080/15412550902905961.; Gøtzsche P.C., Johansen H.K. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst. Rev. 2010; (7): CD007851. DOI:10.1002/14651858.cd007851.pub2.; McElvaney N.G., Burdon J., Holmes M. et al. Long-term efficacy and safety of а1 proteinase inhibitor treatment for emphysema caused by severe а1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). Lancet Respir. Med. 2017; 5 (1): 51-60. DOI:10.1016/S2213-2600(16)30430-1.; https://journal.pulmonology.ru/pulm/article/view/4090
-
3Academic Journal
المؤلفون: E. I. Pervakova, V. V. Vasilets, O. N. Rzhevskaya, N. V. Borovkova, A. V. Pinchuk, Э. И. Первакова, В. В. Василец, О. Н. Ржевская, Н. В. Боровкова, А. В. Пинчук
المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 11, № 3 (2019); 201-208 ; Трансплантология; Том 11, № 3 (2019); 201-208 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2019-11-3
مصطلحات موضوعية: плазмаферез, anti-HLA antibodies, hemodialysis, polymethyl methacrylate, plasmapheresis, анти-HLA-антитела, гемодиализ, полиметилметакрилат
وصف الملف: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/444/514; https://www.jtransplantologiya.ru/jour/article/view/444/527; Lachmann N, Terasaki PI, Schonemann C. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year followup. Clin Transpl. 2006: 171–199. PMID: 18365377; Mizutani K, Shibata L, Ozawa M, Esquenazi V, Rosen A, Miller J, et al. Detection of HLA and MICA antibodies before kidney graft failure. Clin Transpl. 2006: 255–264. PMID: 18365383; Tanabe K, Ishida H, Omoto K, Shimizu T, Shirakawa H. Antibodymediated rejection: a single center experience at Tokyo Women's Medical University. Clin Transpl. 2006: 363–369. PMID: 18365390; Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol. 2010;21(8):1398–1406. PMID: 20634297 https://doi.org/10.1681/ASN.2009101065; Terasaki PI. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transpl. 2004;4:438–443. PMID: 14961999; Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V, et al. Addition of plasmapheresis dicreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol. 2008;3(4):1160–1167. PMID: 18337549 https://doi.org/10.2215/CJN.05321107; Belitsky P, MacDonald AS, Lawen J, McAlister V, Bitter-Suermann H, Kiberd B. Use of rabbit anthymocyte globulin for inducation immunosuppression in high-risk kidney transplant recipients. Transplant Proc. 1997;29(7 Suppl 1):16S–17S. PMID: 9366920 https://doi.org/10.1016/S0041-1345(97)80003-6; Niwa T, Miyazaki T, Maeda K. Removal of furancarboxylic acid, a protein- bound uremic toxin, by hemodialysis using large – pore membrane dialyzer. Jpn J Artif Organs. 1995;24(3):694–696. https://doi.org/10.11392/jsao1972.24.694; Kunitomo T, Takeyama T, Kataoka H. Development of a PMMA membrane which can remove beta 2-microglobulin and its clinical significance. Contrib Nephrol. 1995;112:145–155. PMID: 7554986 https://doi.org/10.1159/000424103; Galli F, Benedetti S, Buoncristiani U, Piroddi M, Conte C, Canestrari F, et al. The effect of PMMA-based proteinleaking dialyzers on plasma homocysteine levels. Kidney Int. 2003;64(2):748–755. PMID: 12846775 https://doi.org/10.1046/j.1523-1755.2003.00134.x; Galli F, Benedetti S, Floridi A, Canestrari F, Piroddi M, Buoncristiani E, et al. Glycoxidation and inflammatory markers in patients on treatment with PMMA- based protein-leaking dialyzers. Kidney Int. 2005;67(2):750–759. PMID: 15673326 https://doi.org/10.1111/j.1523-1755.2005.67138.x; Aoike I. Long-term clinical experience with PMMA membrane. In: Ronco C. (ed.) Polymethylmethacrylate. A flexible membrane for a tailored dialysis. Contributions to Nephrology. Basel, Karger, 1999; 125. р. 205–212.; Ishikawa I, Chikazawa Y, Sato K, Nakagawa M, Imamura H, Hayama S, et al. Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and PMMA) during hemodialysis treatment using SELDI- TOF-MS. Am J Nephrol. 2006;26(4):372–380. PMID: 16873993 https://doi.org/10.1159/000094779; Birk HW, Kistner A, Wizemann V, Schiitterle G. Protein adsorption by artificial membrane materials under filtration condition. Artif Organs. 1995;19:411–415. PMID: 7625919; Lin HH, Liu YL, Liu JH, Chou CY, Yang YF, Kuo HL, et al. Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney. Artif Organs. 2008;32(6):468–472. PMID: 18422797 https://doi.org/10.1111/j.1525-1594.2008.00568.x; Cohen G, Rudnicki M, Schmaldienst S, Horl WH. Effect of dialysis on serum/plasma levels of free immunoglobulin light chains in end-stage renal disease patients. Nephrol Dial Transplant. 2002;17:879–883. PMID: 11981077; Contin C, Pitard V, Delmas Y, Pelletier N, Defrance T, Moreau JF, et al. Potential role of soluble CD40 in the humoral immune response impairment of ureamic patients. Immunology. 2003;110(1):131–140. PMID: 12941150; Hakim RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int. 1984;26(2):194–200. PMID: 6334194; Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, et al. On-Line Haemodiafiltration versus Haemodialy 1. Lachmann N, Terasaki PI, Schonemann C. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year followup. Clin Transpl. 2006: 171–199. PMID: 18365377; Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, et al. On-Line Haemodiafiltration versus Haemodialy; https://www.jtransplantologiya.ru/jour/article/view/444
-
4Academic Journal
المؤلفون: M. Sh. Khubutiya, A. M. Gasanov, E. A. Tarabrin, T. E. Kallagov, E. I. Pervakova, S. A. Krasovskiy, М. Ш. Хубутия, А. М. Гасанов, Е. А. Тарабрин, Т. Э. Каллагов, Э. И. Первакова, С. А. Красовский
المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 11, № 1 (2019); 55-60 ; Трансплантология; Том 11, № 1 (2019); 55-60 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2019-11-1
مصطلحات موضوعية: муковисцидоз, percutaneous endoscopic gastrostomy, cystic fibrosis, чрескожная эндоскопическая гастростомия
وصف الملف: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/422/489; https://www.jtransplantologiya.ru/jour/article/view/422/493; Трансплантация легких: национальные клинические рекомендации. М., 2013. 52 с.; Weill D., Benden C., Corris P.A., et al. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 2015;34(1):1– 15. PMID:25085497 DOI:10.1016/j.healun.2014.06.014; Madill J., Gutierrez C., Grossman J., et al. Nutricional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J. Heart Lung Transplant. 2001;20(3):288–296. PMID:11257554; Rodríguez Ortega P., Calañas Continente A., Molina Puertas M.J., et al. [Percutaneous endoscopic gastrostomy: a 7 years experience longterm tube feeding. Follow-up]. Nutr. Hosp. 2011;26(2):399–401. Spanish. PMID:21666980 DOI:10.1590/S0212-16112011000200023; Hollander F.M., van Pierre D.D., de Roos M.N., et al. Effects of nutricional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation. J. Cyst. Fibros. 2014;13(2):212–218. PMID:24041590 DOI:10.1016/j.jcf.2013.08.009; https://www.jtransplantologiya.ru/jour/article/view/422
-
5Academic Journal
المؤلفون: M. Sh. Khubutiya, A. M. Gasanov, E. A. Tarabrin, T. V. Chernen’kaya, T. E. Kallagov, E. I. Pervakova, М. Ш. Хубутия, А. М. Гасанов, Е. А. Тарабрин, Т. В. Черненькая, Т. Э. Каллагов, Э. И. Первакова
المصدر: PULMONOLOGIYA; Том 29, № 2 (2019); 184-188 ; Пульмонология; Том 29, № 2 (2019); 184-188 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2019-29-2
مصطلحات موضوعية: бронхиальный смыв, pneumonia, lung donor, pulmonary transplant, bronchial washing, пневмония, донор легкого, легочной трансплантат
وصف الملف: application/pdf
Relation: https://journal.pulmonology.ru/pulm/article/view/1144/908; Yeung J.C., Keshavjee S. Overview of clinical lung transplantation. Cold Spring Harb. Perspect. Med. 2014; 4 (1): a015628. DOI:10.1101/cshperspect.a015628.; Weill D., Dey G.C., Hicks R.A. et al. A positive donor gram stain does not predict outcome following lung transplantation. J. Heart Lung Transplant. 2002; 21 (5): 555–558.; Mattner F., Kola A., Fischer S. et al. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection. 2008; 36 (3): 207–212. DOI:10.1007/s15010-007-7157-x.; Campos S., Caramori M., Teixeira R. et al. Bacterial and fungal pneumonias after lung transplantation. Transplant. Proc. 2008; 40 (3): 822–824. DOI:10.1016/j.transproceed.2008.02.049.; Bonde P.N., Patel N.D., Borja M.C. et al. Impact of donor lung organisms on post-lung transplant pneumonia. J. Heart Lung Transplant. 2006; 25 (1): 99–105. DOI:10.1016/j.healun.2005.06.026.; Parada M.T., Alba A., Sepulveda C. Early and late infections in lung transplantation patients. Transplant. Proc. 2010; 42 (1): 333–335. DOI:10.1016/j.transproceed.2009.12.002.; Speich R., van der Bij W. Epidemiology and management of infections after lung transplantation. Clin. Infect. Dis. 2001; 33 (Suppl. 1): S58–65. DOI:10.1086/320906.; Dobbin C., Maley M., Harkness J. et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J. Hosp. Infect. 2004; 56 (4): 277–282. DOI:10.1016/j.jhin.2004.01.003.; Hadjiliadis D., Steele M.P., Chaparro C. et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J. Heart Lung Transplant. 2007; 26 (8): 834–838. DOI:10.1016/j.healun.2007.05.018.; Fischer S.A., Avery R.K. Screening of donor and recipient prior to solid organ transplantation. Am. J. Transplant. 2009; 9 (Suppl. 4): S7–18. DOI:10.1111/j.1600-6143.2009.02888.x.; Singh N., Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J. Heart Lung Transplant. 2003; 22 (3): 258–266.; Sims K.D., Blumberg E.A. Common infections in the lung transplant recipient. Clin. Chest Med. 2011; 32 (2): 327–341. DOI:10.1016/j.ccm.2011.02.010.; Avery R.K. Infections after lung transplantation. Semin. Respir. Crit Care Med. 2006; 27 (5): 544–551. DOI:10.1055/s-2006-954612.; Avery R.K. Antifungal prophylaxis in lung transplantation. Semin. Respir. Crit Care Med. 2011; 32 (6): 717–726. DOI:10.1055/s-0031-1295719.; https://journal.pulmonology.ru/pulm/article/view/1144
-
6Academic Journal
المؤلفون: M. Sh. Khubutiya, M. M. Abakumov, E. V. Klychnikova, E. A. Tarabrin, E. V. Tazina, M. A. Godkov, A. A. Romanov, O. A. Kurilova, E. I. Pervakova, D. Kh. Tsurova, М. Ш. Хубутия, М. М. Абакумов, Е. В. Клычникова, Е. А. Тарабрин, Е. В. Тазина, М. А. Годков, А. А. Романов, О. А. Курилова, Э. И. Первакова, Д. Х. Цурова
المصدر: Russian Journal of Transplantology and Artificial Organs; Том 15, № 3 (2013); 38-43 ; Вестник трансплантологии и искусственных органов; Том 15, № 3 (2013); 38-43 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2013-3
مصطلحات موضوعية: лактат, inhaled nitric oxide, nitrite/nitrate, methemoglobin, lactate, ингаляционный оксид азота, нитрит/нитрат, метгемоглобин
وصف الملف: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/428/370; Kuga T., Mohri M. Bradykinin-induced vasodilatation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. J. Am. Coll. Cardiol. 1997; 30: 108–112.; Cooke J.P., Dzau V.J. Nitric oxide synthase: Role in the genesis of vascular disease. Annu. Rev. Med. 1997; 48: 489–509.; Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., Zapol W.M. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 1993; 328: 399–405.; Ichinose F., Roberts J.D. Jr., Zapol W.M. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation. 2004; 109: 3106–3111.; Young J.D., Sear J.W., Valvini E.M. Kinetics of methae- moglobin and serum nitrogen oxide production during inhalation of nitric oxide in volunteers. Br. J. Anaesth. 1996; 76: 652–656.; Weinberger B., Laskin D.L., Heck D.E., Laskin J.D. The toxicology of inhaled nitric oxide. Toxicol. Sci. 2001; 59 (1): 5–16.; Sokol G.M., Van Meurs K.P., Wright L.L., Rivera O., Thorn W.J., Chu P.M., Sams R.L. Nitrogen dioxide for- mation during inhaled nitric oxide therapy. Clin. Chem. 1999; 45 (3): 382–387.; Kirmse M., Hess D., Fujino Y., Kacmarek R.M., Hur- ford W.E. Delivery of inhaled nitric oxide using the Ohmeda INOvent Delivery System. Chest. 1998; 113 (6): 1650–1657.; Golikov P.P., Nikolaeva N.Yu. Method for determination of nitrite/nitrate (NOx) in serum. Vopr. biomed. himii. 2004; 1: 79–85 (in rus).; Steudel W., Hurford W.E., Zapol W.M. Inhaled nitric oxi- de: basic biology and clinical applications. Anesthesiol- ogy. 1999; 91: 1090–1121.; De Andrade J.A., Crow J.P., Viera L., Bruce Alexan- der C., Randall Young K., McGiffin D.C., Zorn G.L., Zhu S., Matalon S., Jackson R.M. Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts. Am. J. Respir. Crit. Care Med. 2000; 161 (6): 2035–2042.; De Andrade J.A., Crow J., Viera L., Bruce Alexander C., Randall Young K., McGiffin D.C., Zorn G.L., Matalon S., Jackson R.M. Reactive nitrogen species, airway inflam- mation, and fibrosis in lung transplant. Chest. 2001; 120: 58–59.; Reid D., Snell G., Ward C., Krishnaswamy R., Ward R., Zheng L., Williams T., Walters H. Iron overload and nitric oxide-derived oxidative stress following lung transplan- tation. J. Heart Lung Transplant. 2001; 20: 840–849.; Wiklund L., Lewis D.H., Sjöquist P.O., Nilsson F., Taze- laar H., Miller V.M., McGregor C.G. Increased levels of circulating nitrates and impaired endothelium-mediated vasodilation suggest multiple roles of nitric oxide during acute rejection of pulmonary allografts. J. Heart Lung Transplant. 1997; 16 (5): 517–523.; Worrall N.K., Boasquevisque C.H., Misko T.P., Sulli- van P.M., Ferguson T.B. Jr., Patterson G.A. Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J. Heart Lung Transplant. 1997; 16: 334–339.; Johnson M.L., Billiar T.R. Roles of nitric oxide in surgi- cal infection and sepsis. World J. Surg. 1998; 22: 187– 196.; Vospel’nikova N.D. Nitric oxide as a regulator of cellular functions. Biohimicheskie osnovy patologicheskih pro- cessov. Pod red. E.S. Severina. M. Medicina. 2000; 10: 266–291 (in rus).; https://journal.transpl.ru/vtio/article/view/428
-
7Academic Journal
المؤلفون: M. Sh. Khubutia, A. A. Romanov, O. A. Kurilova, V. Kh. Timerbayev, E. I. Pervakova, I. V., Poplavsky, N. N. Levitskaya, A. M. Gasanov, S. V. Galaiko, D. Kh. Tsurova, S. V. Golovinsky, E. A. Tarabrin, М. Ш. Хубутия, А. А. Романов, О. А. Курилова, В. Х. Тимербаев, Э. И. Первакова, И. В., Поплавский, Н. Н. Левицкая, А. М. Гасанов, С. В. Галайко, Д. Х. Цурова, С. В. Головинский, Е. А. Тарабрин
المصدر: General Reanimatology; Том IX № 2 2013 г.; 12 ; Общая реаниматология; Том IX № 2 2013 г.; 12 ; 2411-7110 ; 1813-9779 ; 10.15360/1813-9779-2013-2
مصطلحات موضوعية: primary lung graft dysfunction, pulmonary surfactant system, surfactant-BL, mechanical ventilation, pulmonary oxygenizing dysfunction, extracorporeal membrane oxygenation
وصف الملف: application/pdf
Relation: https://www.reanimatology.com/rmt/article/view/142/75; Thabut G., Vinatier I., SternJ.B., Lemche G., Loirat P., FournierM., MaiH.Chest.; Christie J.D., Van Raemdonck D., de Perrot M., Barr M., Keshavjee S., Arcasoy S.M., Orens J.; ISHLT Working Group on Primary Lung Graft Dysfunction.Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods.J. Heart Lung Transplant.2005; 24 (10): 1451—1453.; Arcasoy S.M., Fisher A., Hachem R.R., Scavuzzo M., Ware L.B.; ISHLT Working Group on Primary Lung Graft Dysfunction.Report of the ISHLT Working Group on Primary Lung Dysfunction part V: predictors and outcomes.J. Heart Lung Tansplant.2005; 24 (10): 1483—1488.; Lee J.C., Christie J.D., Keshavjee S.Primary graft dysfunction: definition, risk, factors, short-and long-term outcomes.Semin. Respir. Crit. Care Med.2010; 31 (2): 161 — 171.; Christie J.D., Kotloff R.M., Pochettino A., Arcasoy S.M., Rosengard B.R., Landis J.R., Kimmel S.E.Clinical risk factors for primary graft failure following lung transplantation.Chest.2003; 124 (4): 1232—1241.; King R.C., Binns O.A., Rodriguez F., Kanithanon R.C., Daniel T.M., Spotnitz W.D., Tribble C.G., Kron I.L.Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation.Ann. Thorac. Surg.2000; 69 (6): 1681—1685.; Knudsen L., Boxler L., Muhlfeld C., Schaefer I.M., Becker L., Bussinger C., von Stietencron I., Madershahian N., Richter J., Wahlers T., Wittwer T., Ochs M.Lung preservation in experimental ischemia/reperfusion injury and lung transplantation: a comparison of natural and synthetic surfactants.J. Heart Lung Transplant.2012; 31 (1): 85—93.; Spragg R.Abnormalities of lung surfactant function in patients with acute lung injury. In: Adult respiratory distress syndrome.Zapol W., Lemaire F. (eds.).New York: Marcel Dekker; 1991: 381—395.; Hallman M., Spragg R., Harrell J.H., Moser K.M., Gluck L.Evidence of lung surfactant abnormality in respiratory failure. Study of bron-choalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.J. Glin. Invest.1982; 70 (3): 673—683.; Голубев А.М., Мороз В.В., Сундуков Д.В.Патогенез острого респираторного дистресс-синдрома.Общая реаниматология.2012; 8 (4): 13—21.; Марченков Ю.В., Власенко А.В., Мороз В.В., Яковлев В.Н.Эволюция диагностики и лечения острого респираторного дистресс-синдрома на основе новейших медицинских технологий.Общаяреаниматология.2012; 8 (4): 22—29.; Duggan M., Kavanagh B.P.Pulmonary atelectasis: a pathogenic periop-erative entity.Anesthesiology.2005; 102 (4): 838—854.; Власенко А.В., Мороз В.В., Яковлев В.Н., Алексеев В.Г., Булатов Н.Н.Выбор способа оптимизации ПДКВ у больных с острым респираторным дистресс-синдромом.Общая реаниматология.2012; 8 (1): 13—21.; Мороз В.В., Власенко А.В., Яковлев В.Н., Алексеев В.Г.Оптимизация ПДКВ у больных с острым респираторным дистресс-синдромом, вызванным прямыми и непрямыми повреждающими факторами.Общаяреаниматология.2012; 8 (3): 5—13.; Baker C.S., Evans T.W., Randle B.J., Haslam P.L.Damage to surfactant-specific protein in acute respiratory distress syndrome.Lancet.1999; 353 (9160): 1232—1237.; Lachmann B.Open up the lung and keep the lung open.Intensive Care Med.1992; 18 (6): 319—321.; КозловИ.А., РомановАА.Маневр открытия («мобилизация») альвеол при интраоперационном нарушении оксигенирующей функции легких у кардиохирургических больных.Анестезиологияиреаниматология.2007; 2: 27—30.; Christie J.D., Carby M., Bag R., Corris P., Hertz M., Weill D.; ISHLT Working Group on Primary Lung Graft Dysfunction.Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation.J. Heart Lung Transplant.2005; 24 (10): 1454—1459.; Verbrugge SJ., Bohm S.H., Gommers D., Zimmerman LJ., Lachmann B.Surfactant impairment after mechanical ventilation with large alveolar surface area changes and effects of positive end-expiratory pressure.Br. J. Anesth.1998; 80 (3): 360—364.; HohlfeldJ.M., Tiryaki E., Hamm H., Hoymann H.G., KrugN., Haverich A., Fabel H.Pulmonary surfactant activity is impaired in lung transplant recipients.Am. J. Respir. Crit. Care Med.1998; 158 (3): 706—712.; Ochs M., Nenadic I., Fehrenbach A., Albes J.M., Wahlers T., Richter J., Fehrenbach H.Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion.Am. J. Respir. Crit. Care Med.1999; 160 (2): 718—724.; Minambres E., Gonzalez-Castro A., Rabanal J.M., Suberviola B., Ortega FJ., Zurbano F, Dfaz-Reganon G., LlorcaJ.Comparative study of two preservation solutions in the initial function after bilateral human lung transplantation.Med. Intensiva.2007; 31 (1): 1—5.; Suarez Lopeza V.J., Minambresa E., Robles Arista J.C., Ballesteros MA.Primary graft dysfunction after lung transplantation.Med. Intensiva.2012; 36 (7): 506—512.; Struber M, HirtS.W.,Cremer J., Harringer W., Haverich A.I.Surfactant replacement injury after clinical lung transplantation.Intensive Care Med.1999; 25 (8): 862—864.; Friedrich I, Splittgerber F.H., Gunther A.Influence of transbronchial surfactant administration on lung function and surfactant attributes after single lung transplantation.J. Heart Lung Transplant.1997; 16 (1): 113.; Eisner M.D., Parsons P., Matthay MA., Greene K.Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.Thorax.2003; 58 (11): 983—988.; ChengI.W., Ware L.B., Greene K.E., Nuckton TJ., Eisner M.D., Matthay MA.Prognostic value of surfactant proteins A and D in patients with acute lung injury.Crit. Care Med.2003; 31 (1): 20—; Shah R.J., Bellamy S.L., Localio A.R., Wickersham N., Diamond J.M., Weinacker A., Lama V.N., Bhorade S., BelperioJA., Crespo M., DemissieE., Kawut S.M., Wille K.M., Lederer DJ., Lee J.C., Palmer S.M., Orens J., Reynolds J, Shah A., Wilkes D.S., Ware L.B., ChristieJ.D.A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.J. Heart Lung Transplant.2012; 31 (9): 942—949.; Розенберг О.А.Легочный сурфактант и его применение при заболеваниях легких.Общаяреаниматология.2007; 3 (1): 66—77.; Veldhuizen R.A., Marcou J., Yao LJ., McCaig L., Ito Y., Lewis J.F.Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits.Am. J. Physiol1996; 270 (1 Pt 1): L152—L158.; Van Iwaarden F.J., van Golde L.Pulmonary surfactant and lung defense. Surfactant therapy for lung disease. In: Lung biology in health and disease.Robertson B., Taeusch H.W. (eds.).N.Y.: Marcel Dekker Inc.; 1995: 75-84.; Козлов ИА., Выжигина МА., Мещеряков Г.А.Сурфактантная система легких.Анестезиологияиреаниматология.1984; 2: 68—73.; Erasmus M.E., Hofstede GJ., Petersen A.H., Batenburg JJ., Haagsman H.P., Oetomo S.B., Prop J.SP-A enriched surfactant for treatment of rat lung transplants with SP-A deficiency after storage and reperfusion.Transplantation.2002; 73 (3): 348—352.; Struber M., Fischer S., NiedermeyerJ., Warnecke G., Gohrbandt B., Gorier A., Simon A.R., Haverich A., Hohlfeld J.M.Effects of exogenous surfactant instillation in clinical lung transplantation; a prospective, randomized trial.J. Thorac. Cardiovasc. Surg.2007; 133 (6): 1620—1625.; AmitalA., ShitritD., Raviv Y., SauteM., Medalion B., BakalL., KramerM.R.The use of surfactant in lung transplantation.Transplantation.2008; 86 (11): 1554—1559.; https://www.reanimatology.com/rmt/article/view/142